Adult ADHD Medications



Date & Location
Friday, November 15, 2024, 12:00 PM - Friday, November 14, 2025, 11:59 PM

Target Audience
Specialties - Anesthesiology, Cardiovascular Disease , Critical Care Medicine, Emergency Medicine, Gastroenterology, Geriatric Medicine , Hematology and Oncology, Hospitalist, Internal Medicine, Interventional Cardiology, Muscoskeletal Radiology, Nephrology, Neurology, Neuromuscular Medicine, Nursing, Obstetrics and Gynecology, Oncology, Orthopaedic Sports Medicine, Orthopaedic Trauma, Orthopedic Surgery, Pain Medicine, Pediatrics, Pharmacy, Physical Medicine and Rehabilitation, Physical Therapy, Preventive Medicine, Psychiatry, Pulmonary Disease, Radiology Diagnostic, Rheumatology, Social Work, Surgery General, Urology

Overview

To educate healthcare providers regarding available stimulant and non-stimulant medications for the treatment of ADHD in adults

Launch Date: November 15, 2024

Expiration Date: November 14, 2025


Objectives
At the conclusion of this activity, participants should be able to:

  1. Identify common symptoms associated with ADHD.
  2. Recall first-line and alternative therapies for treatment of ADHD.
  3. Describe different delivery mechanisms of stimulant medications.

Registration

How to obtain CE Credit:


Please note, you have to watch the entire video in order to receive any CE credit for this online activity.

Click the Tests tile > Launch Video to view the module (create an IUH account if you don't already have one).

Credit will be awarded 30 days post completion.


Accreditation

 

In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and IU Health. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

References:

Magnus W, Nazir S, Anilkumar AC, et al. Attention Deficit Hyperactivity Disorder. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441838/
Mahone EM, Denckla MB. Attention-Deficit/Hyperactivity Disorder: A Historical Neuropsychological Perspective. Journal of the International Neuropsychological Society. 2017;23(9-10):916-929. doi:10.1017/S1355617717000807
Chong CD, Schwedt TJ, Hougaard A. Brain functional connectivity in headache disorders: A narrative review of MRI investigations. Journal of Cerebral Blood Flow & Metabolism. 2019;39(4):650-669. doi:10.1177/0271678X17740794
Mullen S. Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders. In: College of Psychiatric and Neurologic Pharmacists 2020-2021 Psychiatric Pharmacy Review. 2021; 307-352.
American Academy of Family Physicians. Adult ADHD Assessment and Diagnosis. AAFP website. Accessed 18 September 2024. Adult ADHD: Assessment and Diagnosis | AAFP
 Lexi-Drugs/Methylphenidate. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 18, 2024. http://online.lexi.com Accessed September 18, 2024.
Lexi-Drugs/Dextroamphetamine and Amphetamine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 18, 2024. http://online.lexi.com Accessed September 18, 2024
Cohen Children’s Medical Center. ADHD Medication Guide. ADHD Medication Guide website. Accessed September 18, 2024. The ADHD Medication Guide
Lexi-Drugs/Amphetamine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. August 22, 2024. http://online.lexi.com Accessed September 18, 2024
Lexi-Drugs/Dextroamphetamine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 6, 2024. http://online.lexi.com Accessed September 18, 2024
Xelstrym. Noven Therapeutics, LLC. Xelstrym website. Accessed September 18, 2024. ADHD Treatment | Manage Symptoms with Patch Technology (xelstrym.com)
Lexi-Drugs/Lisdexamfetamine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 19, 2024. http://online.lexi.com Accessed September 19, 2024
Lexi-Drugs/Methylphenidate. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 19, 2024. http://online.lexi.com Accessed September 18, 2024
Guzman F. Methylphenidate for ADHD: Mechanism of Action and Formulations. Psychopharmacology Institute website. January 23, 2015. Accessed September 19, 2024. Methylphenidate for ADHD: Mechanism of Action and Formulations - Psychopharmacology Institute
Unique Technology. Tris Pharma. Quillivant XR website. Accessed September 19, 2024. Medication Action | Qullivant XR® (methylphenidate HCl) | Tris Pharma (quillivantxr.com)
Daytrana. Noven Therapetuics, LLC. Daytrana website. Accessed September 19, 2024. DAYTRANA® (methylphenidate) | ADHD medication
Jornay PM. Ironshore. Jornay PM website. Accessed September 19, 2024. JORNAY PM® (methylphenidate HCI)|Official Patient Site
Attention deficit hyperactivity disorder: diagnosis and management. National Institute for Health and Care Excellence. March 14, 2018. Accessed September 19, 2024. Overview | Attention deficit hyperactivity disorder: diagnosis and management | Guidance | NICE
Lexi-Drugs/Viloxazine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. August 22, 2024. http://online.lexi.com Accessed September 18, 2024
Lexi-Drugs/Guanfacine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 3, 2024. http://online.lexi.com Accessed September 18, 2024
Lexi-Drugs/Clonidine. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 18, 2024. http://online.lexi.com Accessed September 18, 2024
Lexi-Drugs/Bupropion. Lexicomp Online. Waltham, MA: Wolters Kluwer Health, Inc. September 17, 2024. http://online.lexi.com Accessed September 18, 2024
Childress AC. Novel Formulations of ADHD Medications: Stimulant Selection and Management. Focus. 2021;19(1):31-38. doi:10.1176/appi.focus.20200032
Clinical Efficacy. Supernus Pharmaceuticals. Quelbree website. Accessed October 10, 2024. Efficacy in Adults with ADHD - Qelbree® HCP (qelbreehcp.com)


Additional Information

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.


Credits
AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours)